2026 Q3 Portfolio Activity
In 2026 Q3, GILEAD SCIENCES, INC. maintained a portfolio of 5 distinct positions.
Position History
hover any row below to update
Loading…
Total Positions
5
Quarter
2026 Q3
Top Holding
RCUS (55.5%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-5 of 5
GILEAD SCIENCES, INC. Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RCUS
Arcus Bioscienc...
|
Healthcare | 55.45% | 58.76% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
31,424,760 | $811,701,551 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-06 | |||
|
GLPG
Lakefront Bioth...
|
Healthcare | 34.24% | 30.34% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
16,707,477 | $501,284,604 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-06 | |||
|
ASMB
Assembly Biosci...
|
Healthcare | 7.99% | 8.30% |
#3
Prev: #3
|
5.2 |
—
|
no change | no change |
P
S
|
4,977,089 | $116,911,821 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-06 | |||
|
KYTX
Kyverna Therape...
|
Healthcare | 1.92% | 2.23% |
#4
Prev: #4
|
2.3 |
—
|
no change | no change |
P
S
|
4,126,119 | $28,057,609 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-06 | |||
|
XLO
Xilio Therapeut...
|
Healthcare | 0.40% | 0.38% |
#5
Prev: #5
|
1.7 |
—
|
no change | no change |
P
S
|
650,389 | $5,886,020 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-06 |
Showing 1-5 of 5 holdings